ABSCI CORP (ABSI) Stock Price, Quote, News and Overview
NASDAQ:ABSI - Nasdaq - US00091E1091 - Common Stock - Currency: USD
ABSI Quote, Performance and Key Statistics
ABSCI CORP
NASDAQ:ABSI (2/10/2025, 8:00:00 PM)
Premarket: 4.25 -0.08 (-1.85%)4.33
-0.34 (-7.28%)
The current stock price of ABSI is 4.33 USD. In the past month the price increased by 51.66%. In the past year, price decreased by -18.76%.
ABSI Latest News and Analysis
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Gapping stocks in Wednesday's session
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses deep learning AI and synthetic biology to expand proteins’ therapeutic potential. The rapid growth of artificial intelligence/machine learning (AI/ML) has led to the emergence of numerous companies that are difficult to tell apart. This challenge is worsened by the fact that clinical proof of concept (POC) in this area is still years away. Recently, Absci entered into a s
Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference
ABSI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.81 | 336.36B | ||
| AMGN | AMGEN INC | 14.87 | 158.46B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1620.59 | 121.03B | ||
| GILD | GILEAD SCIENCES INC | 21.55 | 118.99B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.13 | 75.86B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.66B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.35B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.63B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.41B | ||
| NTRA | NATERA INC | N/A | 22.73B | ||
| BIIB | BIOGEN INC | 8.73 | 20.77B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.18 | 15.43B |
Related stock screener links
About ABSI
Company Profile
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. The company is headquartered in Vancouver Washington, Washington and currently employs 155 full-time employees. The company went IPO on 2021-07-22. The firm combines AI with scalable wet lab technologies to create biologics for patients. The company has built an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. The firm uses its platform to predict, identify, design, construct, screen, select and scale production of biologic drug candidates for its partners, and learn from the data it generates. Its SoluPro technology is a multiplex synthetic biology approach that overcomes the limitations of highest-throughput automation labs. The firm supports its generative AI designs with its wet lab's high-throughput functional validation capabilities. The company reconstructs prevalent immune-response molecules, such as antibodies from disease tissue and identify their corresponding antigens, offering new therapeutic targets.
Company Info
ABSCI CORP
18105 Se Mill Plain Blvd
Vancouver Washington WASHINGTON US
CEO: Sean McClain
Employees: 155
Company Website: https://www.absci.com/
Investor Relations: https://investors.absci.com/
Phone: 13609491041
ABSI FAQ
What is the stock price of ABSI?
The current stock price of ABSI is 4.33 USD.
What is the symbol for ABSCI CORP stock?
The exchange symbol of ABSCI CORP is ABSI and it is listed on the Nasdaq exchange.
On which exchange is ABSI stock listed?
ABSI stock is listed on the Nasdaq exchange.
Is ABSI a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ABSI, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ABSI.
Does ABSI stock pay dividends?
ABSI does not pay a dividend.
What is the Price/Earnings (PE) ratio of ABSI?
ABSI does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.93).
What is the Short Interest ratio of ABSI stock?
The outstanding short interest for ABSI is 23.36% of its float.
ABSI Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ABSI. When comparing the yearly performance of all stocks, ABSI is one of the better performing stocks in the market, outperforming 80.64% of all stocks.
ABSI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ABSI. While ABSI seems to be doing ok healthwise, there are quite some concerns on its profitability.
ABSI Financial Highlights
Over the last trailing twelve months ABSI reported a non-GAAP Earnings per Share(EPS) of -0.93. The EPS increased by 19.48% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -41.52% | ||
| ROE | -48.51% | ||
| Debt/Equity | 0.01 |
ABSI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to ABSI. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of 22.66% and a revenue growth -5.53% for ABSI